Robert Hershberg, Director at NanoString Technologies, holds 107.30K shares in Adaptive Biotechnologies (Ticker: ADPT), holds 1.13M shares in HilleVax, Inc (Ticker: HLVX), holds 38.62K shares in Recursion Pharmaceuticals (Ticker: RXRX).
Robert Hershberg latest transaction was an Uninformative Buy of ―.
What was Robert Hershberg's most profitable transaction?
Robert Hershberg’s most profitable transaction was an Informative Sell of FATE stock on June 6, 2022. The return on the trade was 74.90%.
What is Robert Hershberg's role in NanoString Technologies?
Robert Hershberg's role in NanoString Technologies is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.